DEFA14AThe Ballot
XOMA Royalty Corp files DEFA14A
Filed Apr 27, 2026 · 2mo ago · Accession 0001193125-26-179093
Plain English
This is a supplemental proxy filing (DEFA14A) by XOMA Royalty Corporation regarding a proposed merger with Ligand Pharmaceuticals Incorporated. XOMA Royalty stockholders are asked to approve the merger, which offers a cash payment and a contingent value right (CVR) per share.
Filing details
- Company
- XOMA Royalty Corp
- Ticker
- XOMA
- CIK
- 791908
- Form type
- DEFA14A
- Filing date
- Apr 27, 2026
- Report date
- —
- Document
- d139894ddefa14a.htm
- Size
- 681 KB